Kai-Martin Thoms Selected Research

Kai-Martin Thoms Research Topics

Disease

11	Melanoma (Melanoma, Malignant) 01/2021 - 06/2005
8	Skin Neoplasms (Skin Cancer) 01/2021 - 03/2011
5	Neoplasm Metastasis (Metastasis) 07/2021 - 02/2008
4	Neoplasms (Cancer) 06/2020 - 01/2012
3	Uveal melanoma 01/2022 - 11/2019
3	Wounds and Injuries (Trauma) 01/2022 - 02/2008
2	Hemangioma (Angioma) 01/2020 - 06/2014
2	Pain (Aches) 07/2016 - 02/2008
2	Xeroderma Pigmentosum (Kaposi's Disease) 10/2011 - 03/2011
2	Seroma 02/2008 - 08/2005
1	Thrombosis (Thrombus) 01/2022
1	Hemorrhage 01/2022
1	Diabetes Mellitus 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Exanthema (Rash) 01/2021
1	Ketosis 01/2021
1	Pancreatitis 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2020
1	Myasthenia Gravis 01/2019
1	Myocarditis (Carditis) 01/2019
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2019
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2019
1	Acute Pain 07/2016
1	Neuralgia (Stump Neuralgia) 07/2016
1	Chronic Pain 07/2016
1	Herpes Zoster 07/2016
1	Hyperhidrosis 08/2015
1	Neoplasm Micrometastasis 02/2015
1	Benign Familial Pemphigus (Hailey Hailey Disease) 12/2014
1	Pilonidal Sinus (Pilonidal Cyst) 12/2013
1	Carcinogenesis 03/2011
1	Hypersensitivity (Allergy) 02/2008
1	Wound Infection (Wound Infections) 02/2008
1	Leg Ulcer 12/2007
1	Papilloma (Papillomatosis) 07/2006
1	Cutaneous Malignant Melanoma 08/2005

Drug/Important Bio-Agent (IBA)

8	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
4	IpilimumabIBA 06/2020 - 01/2014
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 11/2019
3	pembrolizumabIBA 10/2020 - 01/2019
3	NivolumabIBA 10/2020 - 01/2019
3	CalcineurinIBA 01/2012 - 03/2011
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012 - 03/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 06/2020
2	Dacarbazine (DIC)FDA LinkGeneric 01/2014 - 10/2009
2	Temozolomide (Temodar)FDA LinkGeneric 06/2011 - 10/2009
2	Coloring Agents (Dyes)IBA 02/2008 - 08/2005
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Factor XIII (Coagulation Factor XIII)IBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	C-PeptideIBA 01/2021
1	VemurafenibIBA 01/2021
1	cobimetinibIBA 01/2021
1	cemiplimabIBA 10/2020
1	AntibodiesIBA 06/2020
1	Propranolol (Inderal)FDA LinkGeneric 01/2020
1	NeodymiumIBA 01/2020
1	tremelimumabIBA 01/2019
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2019
1	CollagenIBA 02/2018
1	purified rayonIBA 02/2018
1	SilverIBA 02/2018
1	FibrinIBA 02/2018
1	Peptide Hydrolases (Proteases)FDA Link 02/2018
1	Analgesics (Analgesic Drugs)IBA 07/2016
1	Botulinum Toxins (Botulinum Toxin)IBA 08/2015
1	Type A Botulinum Toxins (Botox)FDA Link 08/2015
1	PlasticsIBA 01/2013
1	Calcineurin InhibitorsIBA 01/2012
1	MTOR InhibitorsIBA 01/2012
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2012
1	Azathioprine (Imuran)FDA LinkGeneric 01/2012
1	GTP-Binding Proteins (G-Protein)IBA 10/2011
1	MethyltransferasesIBA 06/2011
1	DNA (Deoxyribonucleic Acid)IBA 06/2011
1	Everolimus FDA Link 03/2011
1	Azithromycin (Zithromax)FDA LinkGeneric 07/2006
1	RNA IsoformsIBA 06/2005

Therapy/Procedure

9	Therapeutics 01/2021 - 07/2012
3	Lymph Node Excision (Lymph Node Dissection) 02/2015 - 02/2008
2	Dye Lasers 01/2020 - 06/2014
2	Solid-State Lasers 06/2014 - 12/2013
1	Aftercare (After-Treatment) 01/2021
1	Drug Tapering 01/2021
1	Lasers (Laser) 01/2020
1	Injections 08/2015
1	Gas Lasers 12/2014
1	Hair Removal (Depilation) 12/2013
1	Myocutaneous Flap 01/2013
1	Tattooing 02/2008
1	Fasciotomy 12/2007